Remote effect of deep-seated vascular brain lesions on cerebral blood flow
- Free Univ. of Brussels (Belgium)
We measured regional cerebral blood flow using the xenon-133 inhalation method, at approximately 1 month after onset, in 60 stroke patients who had no evidence of major carotid artery stenosis or occlusion. Their single lesions (43 infarcts and 17 hematomas) were located in the capsulothalamolenticular region, sparing the cortex. Hemispheric mean cerebral blood flow was reduced on the side of the lesion in 25 patients and on both sides in 20. Regional hypoperfusion was observed in 46 patients (ipsilaterally in 34, bilaterally in 10, and contralaterally in two). Regional hypoperfusion was observed most frequently in the frontal lobe, particularly in the motor and premotor cortices of the prerolandic area. The 46 patients with regional hypoperfusion were compared with the 14 patients without regional hypoperfusion, considering the size and location of the lesion as well as the functional and analytic motor performances. As a rule, the lesion was slightly smaller and more posterior and the functional (p less than 0.001) and analytic (p less than 0.05) motor performances were significantly better in the 14 patients without regional hypoperfusion. Since the xenon-133 inhalation method examines cortical blood flow, we can attribute blood flow reductions resulting from deep-seated lesions to a functional depression akin to diaschisis. Interpretation of the clinical consequences and pathogenesis of this phenomenon requires further sequential and pathologic studies.
- OSTI ID:
- 6273873
- Journal Information:
- Stroke; (USA), Vol. 21:11; ISSN 0039-2499
- Country of Publication:
- United States
- Language:
- English
Similar Records
Crossed cerebellar diaschisis and cerebral perfusion reserve in unilateral occlusive cerebrov ascular diseases
Vascular response to carbon dioxide in areas with and without diaschisis in patients with small, deep hemispheric infarction
Related Subjects
CEREBRAL CORTEX
BLOOD FLOW
VASCULAR DISEASES
DIAGNOSIS
PATIENTS
XENON 133
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
BRAIN
CENTRAL NERVOUS SYSTEM
CEREBRUM
DAYS LIVING RADIOISOTOPES
DISEASES
EVEN-ODD NUCLEI
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NUCLEI
ORGANS
RADIOISOTOPES
XENON ISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics